JOURNAL ARTICLE
Fluorouracil, epirubicin, cyclophosphamide (FEC) primary chemotherapy to avoid mastectomy in operable breast cancer
Paolo PedrazzoliPaolo BertoliGiulio Maria FioreP. PretiG. Robustelli della Cuna
Year: 1993 Journal: European Journal of Cancer Vol: 29 Pages: S73-S73 Publisher: Elsevier BV
Keywords:
Epirubicin Cyclophosphamide Medicine Fluorouracil Mastectomy Chemotherapy Oncology Breast cancer Internal medicine Cancer
Metrics
0
Cited By
0.00
FWCI (Field Weighted Citation Impact)
0
Refs
0.12
Citation Normalized Percentile
Is in top 1%
Is in top 10%
Topics
Cancer Treatment and Pharmacology
Health Sciences → Medicine → Oncology
Breast Cancer Treatment Studies
Life Sciences → Biochemistry, Genetics and Molecular Biology → Cancer Research
Advanced Breast Cancer Therapies
Health Sciences → Medicine → Pulmonary and Respiratory Medicine
Related Documents
JOURNAL ARTICLE
Fluorouracil, Epirubicin, and Cyclophosphamide (FEC) for Breast Cancer
John E. MbueDominic A. SolimandoJ. Aubrey Waddell
Journal: Hospital Pharmacy Year: 2008 Vol: 43 (6)Pages: 462-468
JOURNAL ARTICLE
FAC (fluorouracil, doxorubicin, cyclophosphamide) as second line chemotherapy in patients with metastatic breast cancer progressing under FEC (fluorouracil, epirubicin, cyclophosphamide) chemotherapy
G. CatimelFranck ChauvinJean‐Paul GuastallaPaul RebattuPierre BironM. Clavelt
Journal: Annals of Oncology Year: 1994 Vol: 5 (1)Pages: 95-97
JOURNAL ARTICLE
5-Fluorouracil, Adriamycin, Cyclophosphamide (FAC) vs. 5-Fluorouracil, Epirubicin, Cyclophosphamide (FEC) in Metastatic Breast Cancer
Massimo LopezPaola PapaldoLuigi Di LauroPatrizia ViciSilvia CarpanoEttore Conti
Journal: Oncology Year: 1989 Vol: 46 (1)Pages: 1-5
JOURNAL ARTICLE
5-Fluorouracil, Epirubicin and Cyclophosphamide (FEC Combination) in Advanced Breast Cancer
C. ZamagniA. MartoniL. ErcolinoMaría V. BaroniS TannebergerF Pannuti
Journal: Journal of Chemotherapy Year: 1991 Vol: 3 (2)Pages: 126-129
JOURNAL ARTICLE
Blood coagulation during adjuvant epirubicin/cyclophosphamide chemotherapy in patients with primary operable breast cancer.
G.-F. von TempelhoffMartin DietrichGerhard HommelL. Heilmann
Journal: Journal of Clinical Oncology Year: 1996 Vol: 14 (9)Pages: 2560-2568